Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging.
Picano E., Ciampi Q., Cortigiani L., Arruda-Olson AM., Borguezan-Daros C., de Castro E Silva Pretto JL., Cocchia R., Bossone E., Merli E., Kane GC., Varga A., Agoston G., Scali MC., Morrone D., Simova I., Samardjieva M., Boshchenko A., Ryabova T., Vrublevsky A., Palinkas A., Palinkas ED., Sepp R., Torres MAR., Villarraga HR., Preradović TK., Citro R., Amor M., Mosto H., Salamè M., Leeson P., Mangia C., Gaibazzi N., Tuttolomondo D., Prota C., Peteiro J., Van De Heyning CM., D'Andrea A., Rigo F., Nikolic A., Ostojic M., Lowenstein J., Arbucci R., Haber DML., Merlo PM., Wierzbowska-Drabik K., Kasprzak JD., Haberka M., Camarozano AC., Ratanasit N., Mori F., D'Alfonso MG., Tassetti L., Milazzo A., Olivotto I., Marchi A., Rodriguez-Zanella H., Zagatina A., Padang R., Dekleva M., Djordievic-Dikic A., Boskovic N., Tesic M., Giga V., Beleslin B., Di Salvo G., Lorenzoni V., Cameli M., Mandoli GE., Bombardini T., Caso P., Celutkiene J., Barbieri A., Benfari G., Bartolacelli Y., Malagoli A., Bursi F., Mantovani F., Villari B., Russo A., De Nes M., Carpeggiani C., Monte I., Re F., Cotrim C., Bilardo G., Saad AK., Karuzas A., Matuliauskas D., Colonna P., Antonini-Canterin F., Pepi M., Pellikka PA., The Stress Echo Study Group Of The Italian Society Of Echocardiography And Cardiovascular Imaging Siecvi None.
With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025) ≥10,000 patients followed for ≥5 years (up to 2030) from ≥20 quality-controlled laboratories from ≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.